2019•国际医药卫生导报Requires access
Alfacalcidol capsules combined with Xianling Gubao capsules in treatment of postmenopausal osteoporosis
Yu Wang
Open publisher page 1 citations
Abstract
Objective
To observe the clinical effect of alfacalcidol capsules combined with Xianling Gubao capsules in the treatment of postmenopausal osteoporosis (PMOP).
Methods
100 women with PMOP treated at our hospital from October, 2016 to October, 2018 were randomly divided into a control group and a study group, 50 cases for each group. The control group were treated with alfacalcidol capsules, and the study group with alfacalcidol capsules and Xianling Gubao capsules. After two courses of treatment, the clinical effects of both groups were observed. The bone mineral density and adverse reactions were recorded.
Results
The total effective rate was significantly higher in the study group than in the control group (96.00% vs. 82.00%, P 0.05).
Conclusions
Alfacalcidol capsules combined with Xianling Gubao capsules in the treatment of PMOP is effective and has no serious adverse reactions, so it is worth for clinical promotion.
Key words:
Alfacalcidol capsules; Xianling Gubao capsules; Postmenopausal osteoporosis; Clinical effect